Cancer and inflammation

Inflammation influences all stages of tumor development and progression, as well as therapeutic response. Only through careful study of every aspect of the biology of the malignant process can we make real advances in the fight against cancer. A combination of anti-inflammatory approaches targeting the tumor microenvironment should be combined with the use of more complex and selective tumor-killing drugs. The future of anticancer therapy lies in drugs targeting procarcinogenic inflammation.

1. Dilman V.M. Four models of medicine. 1987. (In Russ.).

2. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008;454(7203):436–44. DOI: 10.1038/nature07205

3. Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell 2010;140(6):771–6. DOI: 10.1016/j.cell.2010.03.006

4. Rocha e Silva M. A brief survey of the history of inflammation. Agents Actions 1978;8(1–2):45–9. DOI: 10.1007/BF01972401

5. Zhang K., Shen X., Wu J. et al. Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell 2006;124(3):587–99. DOI: 10.1016/j.cell.2005.11.040

6. Zhang K., Kaufman R.J. From endoplasmic-reticulum stress to the inflammatory response. Nature 2008;454(7203):455–62. DOI: 10.1038/nature07203

7. Hotamisligil G.S., Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 2008;8(12):923–34. DOI: 10.1038/nri2449

8. Kawai T., Akira S. TLR signaling. Cell Death Diff 2006;13(5): 816–25. DOI: 10.1038/sj.cdd.4401850

9. Schroder K., Tschopp J. The inflammasomes. Cell 2010;140(6):821–32. DOI: 10.1016/j.cell.2010.01.040

10. Majno G. The healing hand: man and wound in the ancient world. Cambridge, Mass: Harvard University Press, 1975.

11. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;43(9):1905–15. DOI: 10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P

12. Falkowski P.G., Katz M.E., Milligan A.J. et al. The rise of oxygen over the past 205 million years and the evolution of large placental mammals. Science 2005;309(5744):2202–4. DOI: 10.1126/science.1116047

13. Falkowski P.G. Tracing oxygen’s imprint on earth’s metabolic evolution. Science 2006;311(5768):1724–5. DOI: 10.1126/science.1125937

14. Wynn T.A. IL-13 effector functions. Annu Rev Immunol 2003; 21:425–56. DOI: 10.1146/annurev.immunol.21.120601.141142

15. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340(6):448–54. DOI: 10.1056/NEJM199902113400607

16. Kumar V., Abbas A.K., Fausto N. et al. Pathologic basis of disease. 7th. Philadelphia: Elsevier Saunders, 2005.

17. Trinchieri G. Cancer and inflammation: An old intuition with rapidly evolving new concepts. Annu Rev Immunol.2012; 30:677–706. DOI: 10.1146/annurev-immunol-020711-075008

18. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008;454(7203):428–35. DOI: 10.1038/nature07201

19. Rubanyi G.M. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 1993;22(Suppl 4): S1–14. DOI: 10.1097/00005344-199322004-00002

20. Hedges S.B., Blair J.E., Venturi M.L., Shoe JL. A molecular timescale of eukaryote evolution and the rise of complex multicellular life. BMC Evol Biol 2004;4:2. DOI: 10.1186/1471-2148-4-2

21. Maiuri A.R., O’Hagan H.M. Interplay between inflammation and epigenetic changes in cancer. Prog Mol Biol Transl Sci 2016;144:69–117. DOI: 10.1016/bs.pmbts.2016.09.002

22. Hussain S.P., Hofseth L.J., Harris C.C. Radical causes of cancer. Nat Rev Cancer 2003;3:276–85. DOI: 10.1038/nrc1046

23. Okazaki I.M., Kotani A., Honjo T. Role of AID in tumorigenesis. Adv Immunol 2007;94:245–73. DOI: 10.1016/S0065-2776(06)94008-5

24. DeNardo D.G., Andreu P., Coussens L.M. Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev 2010;29:309–16. DOI: 10.1007/s10555-010-9223-6

25. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010;140(6):883–99. DOI: 10.1016/j.cell.2010.01.025

26. Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010;141(1):39–51. DOI: 10.1016/j.cell.2010.03.01

27. Colotta F., Allavena P., Sica A. et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009;30(7):1073–81. DOI: 10.1093/carcin/bgp127

28. Karnoub A.E., Weinberg R.A. Chemokine networks and breast cancer metastasis. Breast Dis 2006;26:75–85. DOI: 10.3233/bd-2007-26107

29. De Visser K.E., Eichten A., Coussens L.M. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006;6(1):24–37. DOI: 10.1038/nrc1782

30. Soucek L., Lawlor E.R., Soto D. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med 2007;13(10):1211–8. DOI: 10.1038/nm1649

31. Sparmann A., Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 2004;6(5):447–58. DOI: 10.1016/j.ccr.2004.09.028

32. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539–45. DOI: 10.1016/S0140-6736(00)04046-0

33. Vakkila J., Lotze M.T. Inflammation and necrosis promote tumour growth. Nat Rev Immunol 2004;4(8):641–8. DOI: 10.1038/nri1415

34. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006;441(7092):431–6. DOI: 10.1038/nature04870

35. Dvorak H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315(26):1650–9. DOI: 10.1056/NEJM198612253152606

36. Zong W.X., Thompson C.B. Necrotic death as a cell fate. Genes Dev 2006;20(1):1–15. DOI: 10.1101/gad.1376506

37. Retsky M., Demicheli R., Hrushesky W.J.M. et al. Reduction of breast cancer relapses with perioperative non-steroidal antiinflammatory drugs: new findings and a review. Curr Med Chemistry 2013;20(33):4163–76. DOI: 10.2174/09298673113209990250

38. Bishoy F. Cornering metastases: therapeutic targeting of circulating tumor cells and stem cells. Front Oncol 2012:2:68. DOI: 10.3389/fonc.2012.00068

39. Lin W.W., Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007;117(5):1175–83. DOI: 10.1172/JCI31537

40. Becker C., Fantini M.C., Schramm C. et al. TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 2004;21:491–501. DOI: 10.1016/j.immuni.2004.07.020

41. Allan A.L., Vantyghem S.A., Tuck A.B., Chambers A.F. Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis. Breast Disease 2006;26(1):87–98. DOI: 10.3233/bd-2007-26108